Full Length Research Paper
References
Alemu AW, San Sebasti M (2010). Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob. Health Action. 28:3. |
|
Al-Humaid A, Mousa HM, El-Mergawi RA, Abdel-Salam AM (2010). Chemical composition and antioxidant activity of dates and dates-camel-milk mixtures as a protective meal against lipid peroxidation in rats. Am. J. Food Technol. 5(1):22-30. |
|
Asresie A, Yusuf M (2014). Traditional Consumption, Therapeutic Value and Its Derived Dairy Products of Dromedary Camel (Camelus Dromedaries) Milk in Somali Regional State, Eastern Ethiopia: A Review. Glob. J. Anim. Sci. Res. 3(1):240-246. |
|
Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R (1997). Positive effects of combine antiretroviral therapyon CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112-116. |
|
Damtew B, Mengistie B, Alemayehu T (2014). Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan Afr. Med. J. 22(1). |
|
Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan&num JL, Jamieson BD (1998). Changes in thymic function with age and during the treatment of HIV infection. Nature 396(6712):690-695. |
|
Gizachew A, Teha J, Birhanu T, Nekemte E (2014). Review on medicinal and nutritional values of camel milk. Nat. Sci. 12:35-40. |
|
Hirigo AT, Fenta DA, Bala TB, Bule SG, Gemechu MR (2015). Trends of Immuno-virological Response Among HIVInfected Patients Receiving Highly Active Anti-retroviral Therapy at Hawassa, Southern Ethiopia. Clin. Med. Res. 4(4):104-110. |
|
HIV/AIDS Prevention and Control Office (HAPCO) (2014). Country Progress Report on the HIV Response, Federal Democratic Republic of Ethiopia (FDRE), March 2014 Addis Ababa. |
|
Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M (2005). Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to< 500 Cells/µL in HIV Type 1, Infected Individuals Receiving Potent Antiretroviral Therapy. Clin. Infect. Dis. 41(3):361-372. |
|
Lawn SD, Myer L, Bekker LG, Wood R (2006). CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa. BMC Infect Dis. 6:59. |
|
Marston B, De Cock KM (2004). Multivitamins, nutrition, and antiretroviral therapy for HIV disease in Africa. N. Engl. J. Med. 351(1):78-80. |
|
Misgena DK (2011). The pattern of immunologic and virologic responses to Highly Active Antiretroviral Treatment (HAART): Does success bring further challenges?. Ethiop. J. Health Dev. 25(1):61-70. |
|
Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R, Dabis F, Wood R, Sprinz E, Schechter M, Egger M (2008). Long-term immunologic response to antiretroviral therapy in low-income countries: Collaborative analysis of prospective studies: The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration of the International epidemiological Databases to Evaluate AIDS. AIDS 22(17):2291. |
|
Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998). Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection; HIV Outpatient Study Investigators. New Engl. J. Med. 338(13):853-860. |
|
Paton N, Sangeetha S, Earnest A, Bellamy R (2006). The Impact of Malnutrition on Survival and the CD4 Count Response in HIV-Infected Patients Starting Antiretroviral Therapy. HIV Medicine 7:323-30. |
|
Perdigon G, Alvarez S, Rachid M, Agüero G, Gobbato N (1995). Immune system stimulation by probiotics. J. Dairy Sci. 78(7):1597-606. |
|
Raiten DJ, Grinspoon S, Arpadi S (2005). Nutritional considerations in the use of ART in resource-limited settings. Geneva: World Health Organization Department of Nutrition for Health and Development. 2005. |
|
Rougemont M, Stoll BE, Elia N, Ngang P (2009). Antiretroviral treatment adherence and its determinants in Sub-Saharan Africa: a prospective study at Yaounde Central Hospital, Cameroon. AIDS Res. Ther. 6(1):1. |
|
Sieleunou I, Souleymanou M, Schornenberger AM, Menten J, Boelaert M (2008). Determinants of Survival in AIDS Patients on Anti-Retroviral Therapy in a Rural Center in the Far-North Province, Cameroon, Tropical Medicine and International Health 14 (1): 36–43. |
|
Stuart JC, Hamann D, Borleffs J, Roos M, Miedema F, Boucher C, de Boer R (2002). Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age. Aids 16(17):2263-2266. |
|
Wernery R, Yagil R (2012). Medicinal Properties in Camel Milk for Treatment of 'Epidemic' Diseases Proceedings of the 3rd Conference of the International Society of Camelid Research and Development ISOCARD, Muscat, Sultanate of Oman. |
|
World Health Organization (WHO) (2006). Antiretroviral Therapy for HIV infection in Adults and Adolescents: Recommendations for a public health approach 2006 revision. HIV/AIDS Programme: Strengthening health services to fight HIV/AIDS. Geneva: World Health Organization. |
|
Yagil R (2004). Camel milk for health. Available at: http://www.camelmilkforhealth.com. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0